Digital transformation in the pharmaceutical industry is no longer an innovative vision but is becoming a strategic imperative for companies to be competitive in the market. Pharma executives are noticing the impact of digital technologies and realizing that it is crucial for their businesses to implement a strategy around it.
Robert Roe interviews MathWorks Loren Dean, on the use of AI in modelling and simulation
Every device needs to work seamlessly in its operating environment. But when that environment is a human body, things get complicated.
Christian Marcazzo, general manager at IDBS, highlights trends in life sciences research and development.
Data is a company’s biggest asset, yet for any organisation, keeping a handle on the potentially vast volumes and diversity of data that are generated can represent a considerable issue.
Rob Lalonde, Univa’s cloud VP general manager, considers the unique challenges posed by HPC
Deep learning has seen a huge rise in popularity over the last five years in both enterprise and scientific applications.
HPC users are increasingly turning to cloud technologies due to their flexibility and scalability, allowing them to quickly change the size of their workloads, adopt new technologies in a small testing environment and to help to increase the agility of a company working across multiple sites, or
